March 30, 2022
SymBio Pharmaceuticals Limited
Fuminori Yoshida
Representative Director
President and Chief Executive Officer(Securities Code: 4582)

Notice of Shareholder Voting Results for the17th Annual General Meeting of Shareholders
SymBio Pharmaceuticals Limited (“the Company”) today announced the shareholder voting results forthe 17th Annual General Meeting of Shareholders held on March 29th, 2022 (the “ShareholdersMeeting”) as below. All resolutions were approved as proposed by advance voting (by postal mail or theinternet) and the votes exercised in person at the Shareholders Meeting.
1. Resolutions
Proposal 1: Partial amendments to the Articles of Incorporation
The Articles of Incorporation will be partially amended in accordance with the transition to a company
with an audit and supervisory committee in accordance with the recent amendment to the Companies
Act.
Proposal 2: Election of five (5) Directors (excluding Directors serving as Audit & Supervisory CommitteeMembers)
Election of Fuminori Yoshida, Hirotaka Ito, Shigetoshi Matsumoto, Bruce David Cheson, and Eiji
Ebinuma as Directors of the Company.
Proposal 3: Election of three (3) Directors serving as Audit & Supervisory Committee Members
Election of Kiyoshi Watanabe, Kesao Endo, and Yasuhiro Tamou as Audit & Supervisory CommitteeMembers.
Proposal 4: Election of one (1) Director serving as Substitute Audit & Supervisory Committee Member
Election of Takashi Watanabe as Substitute Audit & Supervisory Committee Member.
Proposal 5: Determination of the amount of compensation for Directors (excluding Directors serving as
Audit & Supervisory Committee Members)
Proposal 6: Determination of the amount of compensation for Directors serving as Audit & Supervisory
Committee Members
Proposal 7: Revision of terms and conditions of stock acquisition rights (stock options) issued for
Directors’ Compensation
Owing to recent revisions to the Companies Act, revision of the terms and conditions for issuing stockacquisition rights

12. Number of votes indicating approval, disapproval, abstention, or counted as invalid, andrequirements for the proposed resolutions to be approved and the voting outcome
Total number of votes exercised (including votes exercised at the Shareholders Meeting): 379,522

Resolutions

DisapproInvalid
Approval
valRequir(number(number of(numberementof votes)votes)of votes)

Votingoutcome(%)

Proposal 1
Partial amendments to the Articles ofIncorporation(*)

Approved（95.250）(*)

225

Approved（95.078）
Approved（94.975）
Approved（94.930）
Approved（94.917）
Approved（94.901）

4,241

215

Approved（95.024）

180,236

4,226

215

Yasuhiro Tamou

180,152

4,310

215

Takashi Watanabe

179,926

4,467

286

(*)

Approved（94.867）

Determination of the amount ofcompensation for Directors (excluding
Directors serving as Audit & Supervisory
Committee Members)

173,045

9,722

1,864

(*)

Approved（91.238）

180,645

3,844

182

Fuminori Yoshida180,328

4,128

225

Hirotaka Ito180,133

4,323225

Shigetoshi Matsumoto

180,048

4,408

225

Bruce David Cheson

180,022

4,434

225

Eiji Ebinuma

179,992

4,464

Kiyoshi Watanabe

180,221

Proposal 2

Election of Five (5)Directors(excluding
Directors serving as
Audit & Supervisory
CommitteeMembers)

Proposal 3

Election of one (3)Directors serving as
Audit & Supervisory Kesao Endo
Committee Members(*)

Approved（95.032）
Approved（94.987）

Proposal 4
Election of one (1)Director serving as
Substitute Audit &Supervisory
Committee Member
Proposal 5

Proposal 62Determination of the amount of compensation
for Directors serving as Audit & Supervisory

173,209

9,434

2,038

(*)

Approved（91.325）

171,733

10,881

2,067(*)

Approved（90.546）

Committee Members
Proposal 7
Revision of terms and conditions of stockacquisition rights (stock options) issued
for Directors’ Compensation*

For Proposal 1, more than one-third of shareholders who are eligible to vote need to be present
at the Shareholders Meeting, and more than two-thirds of the votes in favor are required toapprove the resolution.
For Proposals 2 to 4, one-third of shareholders who are eligible to vote need to be present at
the Shareholders Meeting, and more than fifty percent (50%) of the votes in favor are required
to approve the resolutions.
For Proposals 5 to 7, more than fifty percent (50%) of the votes in favor are required toapprove the resolutions.

3. Reason for a portion of the votes exercised at the Shareholders Meeting not reflected in total votes
As the proposed resolutions were approved based on the total of confirmed advance votes and votes
exercised in person at the Shareholders Meeting, certain votes for or against, or abstentions, arenot reflected in the above total votes.
[Contact]
Investor Relations
Tel: +81(0)3 5472 11253